New Paper - Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
Speaker
David Binder, Graduate Student, Schreiber Lab
Date
September 14, 2011, 1:00 pm – 2:00 pm
Location
GCIS
W301
Description
CABI-JC New Paper - Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
Submitting Unit: Committee on Cancer Biology
Type of Event: Journal Club
Date of Event: Wednesday, September 14 2011
Start Time: 12:00 PM
End Time: 1:00 PM
Building: Gordon Center for Integrative Science, Room W301
Name of Series, Lectureship, Ceremony:
CCB Journal Club
Title of talk or presentation:
New Paper - Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
Speaker’s Name and Degrees:
David Binder, Graduate Student, Schreiber Lab
Speaker’s Institutional Affiliation:
UChicago
Description:
COMMITTEE ON CANCER BIOLOGY
JOURNAL CLUB
Wednesday, September 14th , 2011
GCIS W301
12:00pm - 1:00pm
Chimeric Antigen Receptor–Modified
T Cells in Chronic Lymphoid Leukemia
David L. Porter, M.D., Bruce L. Levine, Ph.D., Michael Kalos, Ph.D.,
Adam Bagg, M.D., and Carl H. June, M.D.
N Engl J Med 2011;365:725-33.
Presented By:
David Binder, Graduate Student
Committee on Cancer Biology
Schreiber Laboratory
~ Copies of the paper will be available ~
Contact Name
Biomedical Sciences Cluster
Contact Email
beaudreau@bsd.uchicago.edu
Contact Phone
2-1857
Latest News
Start-up founded by IGSB faculty wins $250,000 Polsky Center award
BiomeSense, a startup developing biosensors that can detect particular kinds of bacteria in patients’ feces that could help improve the efficacy of clinical trials, won the University of Chicago’s Innovation Fund finals and an investment of up to $250,000 from the college.
Massive data analysis shows what drives the spread of flu in the US
Models built with data from health claims, weather, geography and Twitter predict how the flu spreads from the south and southeastern coast
